Publication
Article
Pharmacy Times
Author(s):
Ms. Farley is a freelance medicalwriter based in Wakefield, RI.
An Australian review of 6 clinical trialsfound that diets relying on the GlycemicIndex (GI) effectively achieved weightloss among overweight and obese adultsin the short term.
The GI relies on the effects that certainfoods have on blood sugar levels. Foodsthat are high on the GI include whitebread, potatoes, and rice. Foods low onthe GI include beans, yogurt, and highfibergrains.
Dieters are recommended to eat foodslower on the index.
While there was not a huge difference inweight loss with low—GI diets—2 lb moreweight loss, on average—the diet appearsto be effective in the short term. Dietersshould be aware, however, that the questionof the long-term effectiveness of thisapproach has yet to be determined.
Which is the better predictor of heartdisease: waist-to-hip ratio (WHR) or BMI?A new study suggests that WHR canmore accurately predict one's propensityto developing heart disease. According toresearchers, even a small potbelly isassociated with a higher risk of developingarterial plaque.
A thicker waist will have a greaterimpact on the risk of cardiovascular disease,even if BMI is normal. As peopleage, they need to be more aware ofweight gain in the midsection.
Researchers studied BMI, WHR, andWC (waist circumference). Results showthe following:
Another study has emerged refutingclaims that there is a link between obesityand migraine headaches. The Swedishstudy looked at women aged 40 to 74 tofind an association between high BMIand incidence of migraines. Results didnot detect any link, showing that 32% ofobese women and 38% of nonobesewomen had active migraines—not a significantdifference. Investigator Dr. PeterMattsson of the University Hospital inSweden noted, "If there are true associationsbetween obesity and features ofmigraines such as frequency, these arelikely to be small and cannot be reliablystudied in small or moderately sizedcommunity samples."
Researchers at the Tel Aviv UniversitySackler School of Medicine along withthe drug company Obecure have developedHistalean, a weight-loss drug basedon the vertigo drug betahistine. Availablefor more than 30 years, betahistineblocks the histamine1 and histamine3receptors in the brain, which are connectedto the sense of feeling full andone's desire to eat fatty food. Results ofHistalean use were more significant inwomen. Women under the age of 50who took the drug for 12 weeks lost 7times more weight than those who tookthe placebo. According to 1 study participant,taking the pill "wasn't hard."
Harvard researchers reviewed datafrom 2 large-scale epidemiologic studies—the Nurses' Health Study and theHealth Professionals Follow-up Study—and came to some updated conclusionson the state of fat in one's diet: